| Year |
Citation |
Score |
| 2015 |
Montal ED, Dewi R, Bhalla K, Ou L, Hwang BJ, Ropell AE, Gordon C, Liu WJ, DeBerardinis RJ, Sudderth J, Twaddel W, Boros LG, Shroyer KR, Duraisamy S, Drapkin R, et al. PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth. Molecular Cell. PMID 26481663 DOI: 10.1016/j.molcel.2015.09.025 |
0.327 |
|
| 2015 |
Varma V, Boros LG, Nolen GT, Chang CW, Wabitsch M, Beger RD, Kaput J. Metabolic fate of fructose in human adipocytes: a targeted (13)C tracer fate association study. Metabolomics : Official Journal of the Metabolomic Society. 11: 529-544. PMID 25972768 DOI: 10.1007/s11306-014-0716-0 |
0.315 |
|
| 2013 |
Lamonte G, Tang X, Chen JL, Wu J, Ding CK, Keenan MM, Sangokoya C, Kung HN, Ilkayeva O, Boros LG, Newgard CB, Chi JT. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer & Metabolism. 1: 23. PMID 24359630 DOI: 10.1186/2049-3002-1-23 |
0.324 |
|
| 2013 |
Tedeschi PM, Markert EK, Gounder M, Lin H, Dvorzhinski D, Dolfi SC, Chan LLY, Qiu J, DiPaola RS, Hirshfield KM, Boros LG, Bertino JR, Oltvai ZN, Vazquez A. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells Cell Death and Disease. 4. PMID 24157871 DOI: 10.1038/Cddis.2013.393 |
0.323 |
|
| 2008 |
Harrigan GG, Maguire G, Boros L. Metabolomics in alcohol research and drug development. Alcohol Research & Health : the Journal of the National Institute On Alcohol Abuse and Alcoholism. 31: 26-35. PMID 23584749 |
0.483 |
|
| 2008 |
Vazquez A, Beg QK, Demenezes MA, Ernst J, Bar-Joseph Z, Barabási AL, Boros LG, Oltvai ZN. Impact of the solvent capacity constraint on E. coli metabolism. Bmc Systems Biology. 2: 7. PMID 18215292 DOI: 10.1186/1752-0509-2-7 |
0.343 |
|
| 2008 |
Sarnyai Z, Boros LG. Chapter 20 Modeling Networks of Glycolysis, Overall Energy Metabolism and Drug Metabolism under a Systems Biology Approach Annual Reports in Medicinal Chemistry. 43: 329-349. DOI: 10.1016/S0065-7743(08)00020-1 |
0.418 |
|
| 2007 |
Boros LG, Boros TF. Use of metabolic pathway flux information in anticancer drug design. Ernst Schering Foundation Symposium Proceedings. 189-203. PMID 18811058 |
0.333 |
|
| 2007 |
Maguire G, Boros L, Lee P. Development of tracer-based metabolomics and its implications for the pharmaceutical industry International Journal of Pharmaceutical Medicine. 21: 217-224. DOI: 10.2165/00124363-200721030-00004 |
0.496 |
|
| 2007 |
Centelles JJ, Ramos-Montoya A, Lim S, Bassilian S, Boros LG, Marín S, Cascante M, Lee WP. Metabolic profile and quantification of deoxyribose synthesis pathways in HepG2 cells Metabolomics. 3: 105-111. DOI: 10.1007/s11306-006-0049-8 |
0.364 |
|
| 2006 |
Maguire G, Lee P, Manheim D, Boros L. SiDMAP: a metabolomics approach to assess the effects of drug candidates on the dynamic properties of biochemical pathways. Expert Opinion On Drug Discovery. 1: 351-9. PMID 23495905 DOI: 10.1517/17460441.1.4.351 |
0.512 |
|
| 2005 |
Serkova N, Boros LG. Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 5: 293-302. PMID 16196499 DOI: 10.2165/00129785-200505050-00002 |
0.314 |
|
| 2005 |
Harrigan GG, Brackett DJ, Boros LG. Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini Reviews in Medicinal Chemistry. 5: 13-20. PMID 15638788 |
0.431 |
|
| 2005 |
Boros LG. Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic network Metabolomics. 1: 11-15. DOI: 10.1007/s11306-005-1103-7 |
0.316 |
|
| 2004 |
Marin S, Lee WN, Bassilian S, Lim S, Boros LG, Centelles JJ, FernAndez-Novell JM, Guinovart JJ, Cascante M. Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. The Biochemical Journal. 381: 287-94. PMID 15032751 DOI: 10.1042/BJ20031737 |
0.326 |
|
| 2004 |
Boros LG, Serkova NJ, Cascante MS, Lee WP. Use of metabolic pathway flux information in targeted cancer drug design Drug Discovery Today: Therapeutic Strategies. 1: 435-443. DOI: 10.1016/j.ddstr.2004.11.016 |
0.321 |
|
| 2003 |
Boros LG, Brackett DJ, Harrigan GG. Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP). Current Cancer Drug Targets. 3: 445-53. PMID 14683502 |
0.397 |
|
| 2003 |
Marin S, Chiang K, Bassilian S, Lee WN, Boros LG, Fernández-Novell JM, Centelles JJ, Medrano A, Rodriguez-Gil JE, Cascante M. Metabolic strategy of boar spermatozoa revealed by a metabolomic characterization. Febs Letters. 554: 342-6. PMID 14623091 |
0.322 |
|
| 2002 |
Boros LG, Cascante M, Lee WN. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discovery Today. 7: 364-72. PMID 11893545 |
0.438 |
|
| 2002 |
Cascante M, Boros LG, Comin-Anduix B, de Atauri P, Centelles JJ, Lee PW. Metabolic control analysis in drug discovery and disease. Nature Biotechnology. 20: 243-9. PMID 11875424 DOI: 10.1038/nbt0302-243 |
0.372 |
|
| 2000 |
Comín B, Boren J, Moro C, Martínez S, Lee WP, Boros LG, Centelles JJ, Cascante M. New antitumoral drugs based on ribose-phosphate synthesis tested by metabolic control analysis Biochemical Society Transactions. 28: A220-A220. DOI: 10.1042/bst028a220a |
0.326 |
|
| Show low-probability matches. |